The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global myocardial infarction market is expected to grow from $1.76 billion in 2022 to $1.90 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The myocardial infarction market is expected to reach $2.50 billion in 2027 at a CAGR of 7.1%.

North America held the largest myocardial infarction market share, and Europe was the fastest-growing region in 2022.

Myocardial Infarction Market Driver
An increasing number of smokers is expected to propel the growth of the myocardial infarction market going forward. A smoker is anyone who smokes cigarettes, cigars, or a pipe. Cigarette smoke contains chemicals that cause the blood to thicken and clot in veins and arteries, and a blockage brought on by a clot can result in myocardial infarction. For instance, in October 2021, according to the Cigarette Report published by the Federal Trade Commission, a US-based government agency for consumer protection and competition, the number of cigarettes sold nationally by the major tobacco producers in the US to wholesalers and retailers increased from $202.9 billion in 2019 to $203.7 billion in 2020. Therefore, an increasing number of smokers is driving the growth of the myocardial infarction market.

View More On The Myocardial Infarction Market Report 2023 – https://www.thebusinessresearchcompany.com/report/myocardial-infarction-global-market-report

Prominent Myocardial Infarction Market Trend
Product innovation is a key trend gaining popularity in the myocardial infarction market. Major companies operating in the myocardial infarction market are developing innovative products to sustain their position in the market. For instance, in October 2020, Cadila Pharmaceuticals, an India-based pharmaceutical manufacturing company, launched Tikacad, an antiplatelet medication with ticagrelor, a P2Y12 platelet inhibitor. It is intended to lower the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI).

Myocardial Infarction Market Prominent Players
Major players in the myocardial infarction market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Boehringer Ingelheim GmbH, Merck KGaA, Daiichi Sankyo Co. Ltd., Bio-Rad Laboratories Inc., Apotex Inc., Siemens Healthcare Diagnostics Limited, Annexin Pharmaceuticals AB, Dynavax Technologies Corp, Heartseed Inc., Par Pharmaceutical Companies Inc., Tenaya Therapeutics Inc., Idorsia Pharmaceuticals Ltd., Acesion Pharma ApS, Applied Therapeutics Inc., Athersys Inc., Cardurion Pharmaceuticals Inc., Verve Therapeutics Inc., and Serca Pharmaceuticals AS.

Request A Sample Of The Global Myocardial Infarction Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12164&type=smp

Key Myocardial Infarction Market Segment
The global myocardial infarction market is segmented –
1) By Drug Class: Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers, Vasodilators, Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin-receptor Blockers, Analgesics, Thrombolytics
2) By Route Of Administration: Oral, Injectable
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The Myocardial Infarction Global Market Report 2023  provides a comprehensive overview on the myocardial infarction market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the myocardial infarction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Cardiac Biomarkers Testing Global Market Report 2023
Cardiac Marker Global Market Report 2023
Cardiac Biomarkers Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model